PARIS--(BUSINESS WIRE)--DELBERT Laboratories are proud to announce the acquisition from Noventia Pharma Srl of the European MA of CEPLENE® 0.5mg/0.5ml, solution for injection (histamine dihydrochloride) on September 12, 2022, and strengthens its commitment in hematology-oncology in Europe.
With World Digestive Health Day around, shortly followed by World Allergy Awareness Week (5-11 June), we’re exploring the increasing relevance of a relatively unknown digestive health disorder – histamine intolerance. Estimated to affect 1-3% of the global population[i], we’re highlighting five key things you need to know about histamine intolerance, including why it’s quickly becoming a new focus for innovation in the digestive health space. Read on to learn more about this common, yet unmet consumer need.